Who are thyroid hormone and folinic acid's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/thyroid-hormone-and-folinic-acid.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

thyroid hormone and folinic acid — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

thyroid hormone and folinic acid (thyroid hormone and folinic acid) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hormone replacement and vitamin supplement combination. Area: Endocrinology / Neurodevelopmental disorders.

phase 3 Hormone replacement and vitamin supplement combination Thyroid hormone receptors (TR-α, TR-β); folate metabolism enzymes Endocrinology / Neurodevelopmental disorders Small molecule Live · refreshed every 30 min

Target snapshot

thyroid hormone and folinic acid (thyroid hormone and folinic acid) — Institut Jerome Lejeune. This combination replaces deficient thyroid hormone while folinic acid (leucovorin) supports cellular methylation and one-carbon metabolism, potentially addressing metabolic and neurological dysfunction.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
thyroid hormone and folinic acid TARGET	thyroid hormone and folinic acid	Institut Jerome Lejeune	phase 3	Hormone replacement and vitamin supplement combination	Thyroid hormone receptors (TR-α, TR-β); folate metabolism enzymes

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hormone replacement and vitamin supplement combination class)

Institut Jerome Lejeune · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). thyroid hormone and folinic acid — Competitive Intelligence Brief. https://druglandscape.com/ci/thyroid-hormone-and-folinic-acid. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab